Assyro AI

Orange Book product · Brand (NDA)

LUMASON

SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES

Brand (NDA)NDA 203684RX BRACCO

At a glance

Oct 15, 2014

Approved

Brand (NDA)

Application

Not listed

TE code

5

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 15, 2014

    11 yr 10 mo ago

  2. Today

  3. Patent 10232061 expires

    Listed drug product patent expiration.

    Jul 06, 2038

    in 12 yr 3 mo

  4. Patent 10335502 expires

    Listed drug product patent expiration.

    Jul 06, 2038

    in 12 yr 3 mo

  5. Patent 11723869 expires

    Listed drug product patent expiration.

    May 15, 2039

    in 13 yr 1 mo

  6. Patent 11723869 expires

    Listed drug product patent expiration.

    May 15, 2039

    in 13 yr 1 mo

  7. Patent 11723869 expires

    Listed drug product patent expiration.

    May 15, 2039

    in 13 yr 1 mo

Pharmaceutical detail

Active ingredient

SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES

Strength

60.7MG/25MG

Dosage form

FOR SUSPENSION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 203684

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (5)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10232061Jul 06, 2038in 12 yr 3 mo
Product
10335502Jul 06, 2038in 12 yr 3 mo
Product
11723869May 15, 2039in 13 yr 1 mo
ProductU-3666
11723869May 15, 2039in 13 yr 1 mo
ProductU-3667
11723869May 15, 2039in 13 yr 1 mo
ProductU-3668
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.